Public policy of GST in India: A study on pharmaceutical sector with special reference to Healthcare

Arun Gautam (1) , Shivani Kampani (2) , Gaurav Lodha (3) , Vadera M L (4)
(1) Research Scholar, Department of Commerce, Manipal University Jaipur, India, India ,
(2) Research Scholar, Department of Commerce, Manipal University Jaipur, India, India ,
(3) Department of Commerce, Manipal University Jaipur, India, India ,
(4) School of Business & Commerce, Manipal University Jaipur, India, India

Abstract

India's greatest duty move is now a reality. 1999 was the year when GST was thought of. The amending bill for the full-powered launch of GST was approved by the Rajya Sabha on 8 August 2016, and it was enacted in late August. It is essential to comprehend that GST isn't a duty concession scheme where every good and service has become way cheaper just because the administration has decreased the duty rates. The single Revenue Neutral Rate (RNR) was a difficult system to manage, and thus the Indian govt. I wanted to fix it. Nonetheless, because of practical reasons, "four GST slabs have been set at 5%, 12%, 18%, and 28%. Precious metals have a special rate. The rate of 18% would anyway be relevant for most goods. GST was enacted on 1 July 2017."

Full text article

Generated from XML file

Authors

Arun Gautam
Shivani Kampani
aryan20gautam@gmail.com (Primary Contact)
Gaurav Lodha
Vadera M L
Arun Gautam, Shivani Kampani, Gaurav Lodha, & Vadera M L. (2019). Public policy of GST in India: A study on pharmaceutical sector with special reference to Healthcare. International Journal of Research in Pharmaceutical Sciences, 10(4), 3136–3142. Retrieved from https://ijrps.com/home/article/view/3008

Article Details

No Related Submission Found